IN RE: MODAFINIL ANTITRUST LITIGATION (2016)

United States Court of Appeals, Third Circuit.

IN RE: MODAFINIL ANTITRUST LITIGATION Mylan Laboratories, Inc.; Mylan Pharmaceuticals Inc.; Ranbaxy Laboratories, Ltd; Ranbaxy Pharmaceuticals, Inc., Appellants

No. 15-3475

Decided: September 29, 2016

Before: SMITH, JORDAN, and RENDELL, Circuit Judges

ORDER AMENDING OPINION

The opinion filed September 13, 2016 is amended solely as to the listing of Paul B. Hewitt, Esq. and Catherine Creely, Esq. on the opinion and not as to the substance of the opinion itself. Mr. Hewitt and Ms. Creely should have been listed as members of Akin Gump Strauss Hauer & Feld in Washington, DC. Mr. Hewitt was omitted from the listing of counsel and Ms. Creely was erroneously listed as a member of Cohn & Marks in Washington, DC. The opinion is amended as follows:

Paul B. Hewitt

C. Fairley Spillman

Catherine E. Creely

Akin Gump Strauss Hauer & Feld

1333 New Hampshire Avenue, N.W.

Suite 400

Washington, DC 20036

For the Court,

Marcia M. Waldron, Clerk

Was this helpful?

Why was this helpful?

Easy to understand

Solved my problem

Other

Why was this not helpful?

Missing the information I need

Too complicated / too many steps

Out of date

Other

Thank you for your feedback!

Welcome to FindLaw's Cases & Codes

A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes visit FindLaw's Learn About the Law.

Go To Learn About The Law